Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Insmed Inc (INSM)

Insmed Inc (INSM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,410,777
  • Shares Outstanding, K 101,481
  • Annual Sales, $ 136,470 K
  • Annual Income, $ -254,340 K
  • 60-Month Beta 2.65
  • Price/Sales 24.88
  • Price/Cash Flow N/A
  • Price/Book 8.34

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.59
  • Number of Estimates 4
  • High Estimate -0.51
  • Low Estimate -0.69
  • Prior Year -0.68
  • Growth Rate Est. (year over year) +13.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.28 +27.89%
on 09/04/20
35.32 -4.84%
on 09/16/20
+5.36 (+18.97%)
since 08/25/20
3-Month
25.21 +33.32%
on 07/14/20
35.32 -4.84%
on 09/16/20
+6.47 (+23.84%)
since 06/25/20
52-Week
12.09 +178.00%
on 03/17/20
35.32 -4.84%
on 09/16/20
+15.41 (+84.67%)
since 09/25/19

Most Recent Stories

More News
Insmed Inc Shares Up 89.9% Since SmarTrend's Buy Recommendation (INSM)

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on March 25th, 2020 at $17.88. In approximately 6 months, Insmed Inc has returned 89.93% as of today's recent price of $33.95.

INSM : 33.61 (+0.45%)
Insmed to Host R&D Day on September 30, 2020

, /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will host...

INSM : 33.61 (+0.45%)
Insmed Inc Has Returned 66.8% Since SmarTrend Recommendation (INSM)

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on March 25th, 2020 at $17.88. In approximately 6 months, Insmed Inc has returned 66.77% as of today's recent price of $29.81.

INSM : 33.61 (+0.45%)
Insmed to Present at Three September Conferences

, /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management...

INSM : 33.61 (+0.45%)
New England Journal of Medicine Publishes Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis

, /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that final results...

INSM : 33.61 (+0.45%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

, /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of...

INSM : 33.61 (+0.45%)
Insmed Inc Shares Up 57.9% Since SmarTrend's Buy Recommendation (INSM)

SmarTrend identified an Uptrend for Insmed Inc (NASDAQ:INSM) on March 25th, 2020 at $17.88. In approximately 5 months, Insmed Inc has returned 57.87% as of today's recent price of $28.22.

INSM : 33.61 (+0.45%)
Baudax Bio Appoints Arnold Baskies, M.D. and Andrew Drechsler to Board of Directors

Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Arnold Baskies, M.D. and Andrew Drechsler, have been appointed to the Company's...

INSM : 33.61 (+0.45%)
BXRX : 3.01 (-1.31%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

, Aug. 7, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the...

INSM : 33.61 (+0.45%)
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates

Insmed (INSM) delivered earnings and revenue surprises of -10.34% and 16.58%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

INSM : 33.61 (+0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade INSM with:

Business Summary

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas...

See More

Key Turning Points

2nd Resistance Point 34.38
1st Resistance Point 34.00
Last Price 33.61
1st Support Level 33.08
2nd Support Level 32.54

See More

52-Week High 35.32
Last Price 33.61
Fibonacci 61.8% 26.45
Fibonacci 50% 23.70
Fibonacci 38.2% 20.96
52-Week Low 12.09

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar